Microglial TIR-domain-containing adapter-inducing interferon-β (TRIF) deficiency promotes retinal ganglion cell survival and axon regeneration via nuclear factor-κB
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Microglial TIR-domain-containing adapter-inducing interferon-β (TRIF) deficiency promotes retinal ganglion cell survival and axon regeneration via nuclear factor-κB
Authors
Keywords
-
Journal
Journal of Neuroinflammation
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2012-02-24
DOI
10.1186/1742-2094-9-39
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual Signaling of MyD88 and TRIF Is Critical for Maximal TLR4-Induced Dendritic Cell Maturation
- (2014) H. Shen et al. JOURNAL OF IMMUNOLOGY
- Trans-Chalcone prevents VEGF expression and retinal neovascularization in the ischemic retina
- (2011) Folami Lamoke et al. EXPERIMENTAL EYE RESEARCH
- Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10
- (2011) Yun Sang Lee et al. IMMUNOLOGY
- Retinal ganglion cell death is induced by microglia derived pro-inflammatory cytokines in the hypoxic neonatal retina
- (2011) Viswanathan Sivakumar et al. JOURNAL OF PATHOLOGY
- Anti-neuroinflammatory Activity of Nobiletin on Suppression of Microglial Activation
- (2010) Yanji Cui et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNα/β and IL-1β responses in the diseased brain and exacerbates chronic neurodegeneration
- (2010) Robert Field et al. BRAIN BEHAVIOR AND IMMUNITY
- A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type
- (2010) Shekoufeh Nikfar et al. CLINICAL THERAPEUTICS
- HMBG1 Mediates Ischemia—Reperfusion Injury by TRIF-Adaptor Independent Toll-Like Receptor 4 Signaling
- (2010) Qing-Wu Yang et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Double-Stranded RNA Induces Shedding of the 34-kDa Soluble TNFR1 from Human Airway Epithelial Cells via TLR3-TRIF-RIP1-Dependent Signaling: Roles for Dual Oxidase 2- and Caspase-Dependent Pathways
- (2010) M. Yu et al. JOURNAL OF IMMUNOLOGY
- IFN -1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum
- (2010) J. Shimizu et al. NEUROLOGY
- Microglial activation and chronic neurodegeneration
- (2010) Melinda E. Lull et al. Neurotherapeutics
- Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells
- (2009) A Weber et al. CELL DEATH AND DIFFERENTIATION
- Therapie von Sehnerverkrankungen – der aktuelle Stand
- (2009) W. Lagrèze KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
- Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production
- (2009) Mikyoung Chang et al. NATURE IMMUNOLOGY
- Mst3b, an Ste20-like kinase, regulates axon regeneration in mature CNS and PNS pathways
- (2009) Barbara Lorber et al. NATURE NEUROSCIENCE
- Oncomodulin links inflammation to optic nerve regeneration
- (2009) Y. Yin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- KLF Family Members Regulate Intrinsic Axon Regeneration Ability
- (2009) D. L. Moore et al. SCIENCE
- The Optic Nerve
- (2009) John Selhorst et al. SEMINARS IN NEUROLOGY
- Toll-like receptor 4 restricts retinal progenitor cell proliferation
- (2008) Ravid Shechter et al. JOURNAL OF CELL BIOLOGY
- Production and functions of IL-17 in microglia
- (2008) Jun Kawanokuchi et al. JOURNAL OF NEUROIMMUNOLOGY
- Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway
- (2008) K. K. Park et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started